(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIOAEGIS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BIOAEGIS

ST13

US500000088631291

Class

5, 42

Filing

88631291

Registration

6037100

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

07/23/2026

Trademark type

Word

Nice classes

5, 42

Filing date

09/25/2019

Registration date

04/21/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/21/2020

Last transaction

07/23/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

09/12/2014

First use in commerce

09/12/2014

Drawing code

4

Owner type

03

Owner location

North Brunswick, NJ, US

Examiner

FLOWERS, JAY K

Current location

Historical data usage

Holders and representatives

Holders

BioAegis Therapeutics, Inc.

Representatives

Delphine W. Knight Brown Hecht Partners LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment of inflammationautoimmune diseases and disordersdegenerative diseases and disordersmetabolic diseases and disorders and infectious diseases and disorders; Therapeutic pharmaceutical for the treatment of inflammationautoimmune diseases and disordersdegenerative diseases and disordersmetabolic diseases and disorders and infectious diseases and disorders

Class 42

Research and development in the field of technology and diagnostics in the field of immunotherapyinflammationautoimmune diseases and disordersdegenerative diseases and disordersmetabolic diseases and disorders and infectious diseases and disorders; Research and development in the pharmaceutical and biotechnology fields

Publications

History of USPTO decisions and trademark events.

22 publications found

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

07/23/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/23/2026

E815

TEAS SECTION 8 & 15 RECEIVED

04/20/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/21/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/10/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/10/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/10/2023

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

01/10/2023

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

01/10/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/09/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/09/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/09/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/09/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/09/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

04/21/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/04/2020

PUBO

PUBLISHED FOR OPPOSITION

02/04/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/15/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/27/2019

DOCK

ASSIGNED TO EXAMINER

12/27/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/01/2019

NWAP

NEW APPLICATION ENTERED

09/28/2019

Continuous trademark protection

Get notified about every new filing that threatens BIOAEGIS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.